HEPATITIS C (HCV): Clinical Trials

3 trials for HEPATITIS C (HCV), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Not yet recruiting 2, Recruiting 1

Follow HEPATITIS C (HCV): new trials by email Literature Review of HEPATITIS C (HCV) trials Research Report on HEPATITIS C (HCV)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combating Related Epidemics in HCV
Cepheid GeneXpert HCV Test, INSTI HIV - 1/2 Antibody, bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV)
Phase 4Not yet recruitingDuke University12802027-01-202026-11-18
AI-Powered Hepatitis C Single-Encounter Test-and-Treat
Epclusa (sofosbuvir and velpatasvir) - HEPATITIS C (HCV)
Phase 4Not yet recruitingPatrick Grace352026-12-012026-08-28
Implementing Low-Barrier HCV Treatment in a Jail Setting
Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Community Health Worker - HEPATITIS C (HCV), Incarceration
Phase 4RecruitingLifespan402025-06-112026-02-27

Narrower conditions

Hepatitis C (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Hepatitis B (1)

Broader conditions

Blood-Borne Infections (3)  ·  Communicable Diseases (3)  ·  Digestive System Diseases (3)  ·  Flaviviridae Infections (3)  ·  Hepatitis (3)  ·  Hepatitis, Viral, Human (3)  ·  Infections (3)  ·  Liver Diseases (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  DNA Virus Infections (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Hepadnaviridae Infections (1)  ·  Immune System Diseases (1)

Interventions

Sofosbuvir (3)  ·  sofosbuvir-velpatasvir drug combination (3)  ·  velpatasvir (3)  ·  Community Health Workers (1)  ·  sofosbuvir velpatasvir voxilaprevir drug combination (1)

Sponsors

Duke University (1)  ·  Lifespan (1)  ·  Patrick Grace (1)

Countries

United States (2)

Top investigators

Susanna Naggie, MD, MHS (1)

Results publications

PMID 41027703

NIH funding

R34DA061732 (1), U01AI195193 (1)